hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Ferroptosis: Opportunities and Challenges in
Ferroptosis: Opportunities and Challenges in Cancer Targeted therapy for drug tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours British Journal of Cancer JCI Insight Mitochondrial metabolic rewiring sensitizes mTORC1 inhibitor persister cells to cuproptosis JCI CD8+ T cells sustain antitumor response by mediating crosstalk between adenosine A2A receptor and glutathione GPX4 FSP1 and histone deacetylases suppress cancer persister cell ferroptosis Science Advances
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




